Dr. Joseph Mercola - Take Control of Your Health podkast

Blockbuster Anticlotting Drug Approved on Flawed Studies

0:00
7:29
Do tyłu o 15 sekund
Do przodu o 15 sekund
  • Ticagrelor, a blockbuster anticlotting drug, was approved despite FDA scientists warning it looked less safe and effective than older, cheaper alternatives like clopidogrel
  • The landmark PLATO trial used to secure approval showed U.S. patients had worse outcomes on ticagrelor, yet those results were overridden by FDA leadership
  • Investigations revealed serious problems with the trial, including altered death records, missing data, and inconsistent monitoring that favored ticagrelor
  • Follow-up platelet studies were also misreported, with non-significant results published as significant and some listed authors denying participation
  • Knowing these flaws allows you to ask about proven alternatives, reduce your personal heart risk through lifestyle, and avoid dependence on drugs pushed forward with weak, flawed evidence

Więcej odcinków z kanału "Dr. Joseph Mercola - Take Control of Your Health"